Litcius/Paper detail

Grade-Targeted Nanoparticles for Improved Hypoxic Tumor Microenvironment and Enhanced Photodynamic Cancer Therapy

Yingkai Tao, Xiaoyang Hou, Huan Gao, Xin Zhang, Fengmei Zuo, Yun Wang, Xinxin Li, Guan Jiang

2021Nanomedicine16 citationsDOI

Abstract

Background: The hypoxia of the tumor microenvironment (TME), low transfer efficiency of photosensitizers and limited diffusion distance of reactive oxygen species restrict the application of photodynamic therapy (PDT). Aim: To produce TME-responsive and effective nanoparticles for sensitizing PDT. Materials & methods: CD44 and mitochondria grade-targeted hyaluronic acid (HA)-triphenylphosphine (TPP)-aminolevulinic acid (ALA)-catalase (CAT) nanoparticles (HTACNPs) were synthesized via a modified double-emulsion method. In vitro and in vivo experiments were performed to investigate the antitumor efficacy of HTACNP-mediated PDT. Results: HTACNPs specifically targeted MV3 cells and the mitochondria and produced O2 to relieve TME hypoxia. HTACNP-mediated PDT produced reactive oxygen species to induce irreversible cell apoptosis. HTACNP-PDT inhibited melanoma growth effectively in vivo. Conclusion: HTACNP-mediated PDT improved TME hypoxia and effectively enhanced PDT for cancer.

Topics & Concepts

Photodynamic therapyTumor microenvironmentCancer researchCancer therapyCancerMedicineChemistryInternal medicineTumor cellsOrganic chemistryNanoplatforms for cancer theranosticsPhotodynamic Therapy Research StudiesAdvanced Nanomaterials in Catalysis